ロード中...
Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells
Adoptive transfer of T cells expressing a CD19-specific chimeric antigen receptor (CAR) is being evaluated in multiple clinical trials. Our current approach to adoptive immunotherapy is based on a second generation CAR (designated CD19RCD28) that signals through a CD28 and CD3-ζ endodomain. T cells...
保存先:
主要な著者: | , , , , , , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Public Library of Science
2013
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3669363/ https://ncbi.nlm.nih.gov/pubmed/23741305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0064138 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|